Compare · CCM vs HIMS
CCM vs HIMS
Side-by-side comparison of Concord Medical Services Holdings Limited (CCM) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CCM and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.06B, about 292.1x CCM ($20.8M).
- Over the past year, CCM is down 33.9% and HIMS is down 53.2% - CCM leads by 19.2 points.
- HIMS has been more active in the news (20 items in the past 4 weeks vs 1 for CCM).
- HIMS has more recent analyst coverage (25 ratings vs 0 for CCM).
- Company
- Concord Medical Services Holdings Limited
- Hims & Hers Health Inc.
- Price
- $4.71-2.69%
- $26.64+1.72%
- Market cap
- $20.8M
- $6.06B
- 1M return
- +4.20%
- +3.76%
- 1Y return
- -33.94%
- -53.16%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NYSE
- IPO
- 2024
- 2019
- News (4w)
- 1
- 20
- Recent ratings
- 0
- 25
Concord Medical Services Holdings Limited
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in Network and Hospital segments. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. It also offers other treatments and diagnostic services comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. In addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, it offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as tele-consulting services; and sells medical equipment. Additionally, the company establishes the Beijing Proton Medical Center that provides radiotherapy treatment options to cancer patients; and other specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of June 30, 2019, it operated a network of 30 centers based in 20 hospitals in 20 cities across 13 provinces and administrative regions in China. Concord Medical Services Holdings Limited was incorporated in 2007 and is headquartered in Beijing, the People's Republic of China.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest CCM
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025
- SEC Form 20-F filed by Concord Medical Services Holdings Limited
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- SEC Form 3 filed by new insider Yang Jianyu
- SEC Form 3 filed by Concord Medical Services Holdings Limited
- SEC Form 3 filed by Concord Medical Services Holdings Limited
- SEC Form 3 filed by Concord Medical Services Holdings Limited
Latest HIMS
- Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits
- Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians
- Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany
- Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World's Largest Consumer Health Platform
- Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market
- Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform
- Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
- Director Wells David B bought $1,172,974 worth of shares (48,400 units at $24.23), increasing direct ownership by 27% to 224,417 units (SEC Form 4)
- SEC Form 4 filed by Chief Medical Officer Carroll Patrick Harrison